Pandite Arundathy N. 4
4 · Shattuck Labs, Inc. · Filed Jan 28, 2025
Insider Transaction Report
Form 4
Pandite Arundathy N.
Chief Medical Officer
Transactions
- Award
Common Stock
2025-01-28+206,200→ 206,200 totalExercise: $1.18Exp: 2035-01-28→ Common Stock (206,200 underlying) - Tax Payment
Common Stock
2025-01-25$1.16/sh−3,211$3,725→ 206,265 total
Footnotes (1)
- [F1]This option represents a right to purchase a total of 206,200 shares of the Issuer's common stock, one quarter of which will vest on January 28, 2026, with the remaining three quarters vesting in equal monthly installments through January 28, 2029, subject to the Reporting Person's continued service to the Issuer.